A new report released April 10, 2018 by The Partnership for Safe Medicines (PSM) illustrates the growing deadly toll that illegally-imported fentanyl is having on communities throughout the U.S. PSM’s analysis confirms reports of counterfeit medicines made with fentanyl in 43 states, with fentanyl-related deaths confirmed in 22 states. The updated findings follow a report released by PSM last September that found a presence of counterfeit fentanyl in 40 states and related deaths in 16 states.

[...]

  ABSTRACT The rise of digital technologies has created a complex online environment that now includes illicit Internet pharmacies, online facilitators, advertising sites, and foreign entities. Collectively, these networks create significant patient safety risks, including acting as unregulated access points encouraging prescription drug use. Although law enforcement is active in combatting this form of cybercrime,…

[...]

A new report released April 10, 2018 by The Partnership for Safe Medicines (PSM) illustrates the growing deadly toll that illegally-imported fentanyl is having on communities throughout the U.S. PSM’s analysis confirms reports of counterfeit medicines made with fentanyl in 43 states, with fentanyl-related deaths confirmed in 22 states. The updated findings follow a report released by PSM last September that found a presence of counterfeit fentanyl in 40 states and related deaths in 16 states.

[...]

BackgroundDigital forms of direct-to-consumer pharmaceutical marketing (eDTCA) have globalized in an era of free and open information exchange. Yet, the unregulated expansion of eDTCA has resulted in unaddressed global public health threats. Specifically, illicit online pharmacies are engaged in the sale of purportedly safe, legitimate product that may in fact be counterfeit or substandard. These…

[...]

ABSTRACT BACKGROUND: Promotion of prescription drug coupons and vouchers by pharmaceutical manufacturers has increased in recent years. These coupons and vouchers usually subsidize patients’ cost-sharing obligations. In other words, drug companies pay for a patient’s portion of the drug cost, and the remaining cost is paid by the patient and the patient’s health plan. This…

[...]

BACKGROUND: Existing federal law requires that a 72-hour emergency supply of a prescription drug be dispensed to Medicaid patients when prior authorization (PA) is not available and the medication is needed without delay. The pharmacist’s role is to contact prescribers and inform them that PA is needed. If the prescriber cannot be reached, the pharmacist can dispense a 72-hour emergency supply.

OBJECTIVES: To determine (a) the reasons why some community pharmacy owners/managers, staff pharmacists, and technicians are not compliant with the law; (b) how often the decision is made; and (c) estimate how often pharmacies do not dispense the 72-hour emergency supply when PA is not available.

[...]